1104 related articles for article (PubMed ID: 22508028)
1. Patient-derived tumour xenografts as models for oncology drug development.
Tentler JJ; Tan AC; Weekes CD; Jimeno A; Leong S; Pitts TM; Arcaroli JJ; Messersmith WA; Eckhardt SG
Nat Rev Clin Oncol; 2012 Apr; 9(6):338-50. PubMed ID: 22508028
[TBL] [Abstract][Full Text] [Related]
2. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
Kelland LR
Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
[TBL] [Abstract][Full Text] [Related]
3. Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review.
Jin K; Teng L; Shen Y; He K; Xu Z; Li G
Clin Transl Oncol; 2010 Jul; 12(7):473-80. PubMed ID: 20615824
[TBL] [Abstract][Full Text] [Related]
4. Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies.
Bagby S; Messersmith WA; Pitts TM; Capasso A; Varella-Garcia M; Klauck PJ; Kim J; Tan AC; Eckhardt SG; Tentler JJ; Arcaroli J
J Vis Exp; 2016 Sep; (115):. PubMed ID: 27768028
[TBL] [Abstract][Full Text] [Related]
5. Kinomic profiling of tumour xenografts derived from patients with non-small cell lung cancer confirms their fidelity and reveals potentially actionable pathways.
Tabbò F; Guerrera F; van den Berg A; Gaudiano M; Maletta F; Bessone L; Nottegar A; Costardi L; de Wijn R; Ruijtenbeek R; Delsedime L; Sapino A; Ruffini E; Hilhorst R; Inghirami G
Eur J Cancer; 2021 Feb; 144():17-30. PubMed ID: 33316635
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived tumour xenografts for breast cancer drug discovery.
Cassidy JW; Batra AS; Greenwood W; Bruna A
Endocr Relat Cancer; 2016 Dec; 23(12):T259-T270. PubMed ID: 27702751
[TBL] [Abstract][Full Text] [Related]
7. Molecular and clinical implementations of ovarian cancer mouse avatar models.
Zayed AA; Mandrekar SJ; Haluska P
Chin Clin Oncol; 2015 Sep; 4(3):30. PubMed ID: 26408297
[TBL] [Abstract][Full Text] [Related]
8. Patient-derived xenografts as preclinical neuroblastoma models.
Braekeveldt N; Bexell D
Cell Tissue Res; 2018 May; 372(2):233-243. PubMed ID: 28924803
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived tumor xenograft model to guide the use of BRAF inhibitors in metastatic melanoma.
Guerreschi P; Scalbert C; Qassemyar A; Kluza J; Ravasi L; Huglo D; Martinot-Duquennoy V; Formstecher P; Marchetti P; Mortier L
Melanoma Res; 2013 Oct; 23(5):373-80. PubMed ID: 23852164
[TBL] [Abstract][Full Text] [Related]
10. [Advances in Patient Derived Tumor Xenograft (PDTX) Model from Lung Cancer].
Qin B; Jiao X; Yuan L; Liu K; Zang Y
Zhongguo Fei Ai Za Zhi; 2017 Oct; 20(10):715-719. PubMed ID: 29061220
[TBL] [Abstract][Full Text] [Related]
11. A Multicentre Clinical Study of Sarcoma Personalised Treatment Using Patient-Derived Tumour Xenografts.
Xu H; Zheng H; Zhang Q; Song H; Wang Q; Xiao J; Dong Y; Shen Z; Wang S; Wu S; Wei Y; Lu W; Zhu Y; Niu X
Clin Oncol (R Coll Radiol); 2023 Jan; 35(1):e48-e59. PubMed ID: 35781406
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived xenografts: A platform for accelerating translational research in prostate cancer.
Davies AH; Wang Y; Zoubeidi A
Mol Cell Endocrinol; 2018 Feb; 462(Pt A):17-24. PubMed ID: 28315377
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of patient-derived tumor xenograft using gastroscopic biopsies in gastric cancer.
Zhu Y; Tian T; Li Z; Tang Z; Wang L; Wu J; Li Y; Dong B; Li Y; Li N; Zou J; Gao J; Shen L
Sci Rep; 2015 Feb; 5():8542. PubMed ID: 25712750
[TBL] [Abstract][Full Text] [Related]
14. Orthotopic and metastatic tumour models in preclinical cancer research.
Stribbling SM; Beach C; Ryan AJ
Pharmacol Ther; 2024 May; 257():108631. PubMed ID: 38467308
[TBL] [Abstract][Full Text] [Related]
15. Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery.
Fiebig HH; Maier A; Burger AM
Eur J Cancer; 2004 Apr; 40(6):802-20. PubMed ID: 15120036
[TBL] [Abstract][Full Text] [Related]
16. The role of mouse tumour models in the discovery and development of anticancer drugs.
Ireson CR; Alavijeh MS; Palmer AM; Fowler ER; Jones HJ
Br J Cancer; 2019 Jul; 121(2):101-108. PubMed ID: 31231121
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived xenografts as in vivo models for research in urological malignancies.
Inoue T; Terada N; Kobayashi T; Ogawa O
Nat Rev Urol; 2017 May; 14(5):267-283. PubMed ID: 28248952
[TBL] [Abstract][Full Text] [Related]
18. Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?
Merk J; Rolff J; Becker M; Leschber G; Fichtner I
Eur J Cardiothorac Surg; 2009 Sep; 36(3):454-9. PubMed ID: 19502076
[TBL] [Abstract][Full Text] [Related]
19. Patient-derived tumor xenograft models for melanoma drug discovery.
Harris AL; Joseph RW; Copland JA
Expert Opin Drug Discov; 2016 Sep; 11(9):895-906. PubMed ID: 27454070
[TBL] [Abstract][Full Text] [Related]
20. Patient-Derived Xenograft: An Adjuvant Technology for the Treatment of Metastatic Disease.
Bousquet G; Janin A
Pathobiology; 2016; 83(4):170-6. PubMed ID: 27010922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
